Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.
Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J. Ono M, et al. Among authors: yoshida m. Oncotarget. 2016 Jun 21;7(25):38586-38597. doi: 10.18632/oncotarget.9558. Oncotarget. 2016. PMID: 27233074 Free PMC article.
Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
Hashii Y, Yoshida M, Hara J, Nishimura S, Yumura-Yagi K, Horibe K, Nakahata T. Hashii Y, et al. Among authors: yoshida m. J Pediatr Hematol Oncol. 2018 Jul;40(5):374-378. doi: 10.1097/MPH.0000000000001193. J Pediatr Hematol Oncol. 2018. PMID: 29697579 Clinical Trial.
Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
Toriumi N, Kobayashi R, Yoshida M, Iguchi A, Sarashina T, Okubo H, Suzuki D, Sano H, Ogata M, Azuma H. Toriumi N, et al. Among authors: yoshida m. J Pediatr Hematol Oncol. 2014 Jul;36(5):379-83. doi: 10.1097/MPH.0b013e3182a11676. J Pediatr Hematol Oncol. 2014. PMID: 23929317
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H, Kudoh T, Nishimura S, Oda M, Yoshida M, Hara J, Tawa A, Usami I, Tanizawa A, Yumura-Yagi K, Kato K, Kobayashi R, Komada Y, Matsuo K, Horibe K; Japan Association of Childhood Leukemia Study. Hori H, et al. Among authors: yoshida m. Int J Clin Oncol. 2017 Apr;22(2):387-396. doi: 10.1007/s10147-016-1062-1. Epub 2016 Nov 17. Int J Clin Oncol. 2017. PMID: 27858183 Clinical Trial.
Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, Komada Y, Hara J, Tawa A, Usami I, Tanizawa A, Kato K, Kobayashi R, Matsuo K, Hori H; Japan Association of Childhood Leukemia Study (JACLS), Japan. Horibe K, et al. Among authors: yoshida m. J Pediatr Hematol Oncol. 2017 Mar;39(2):81-89. doi: 10.1097/MPH.0000000000000760. J Pediatr Hematol Oncol. 2017. PMID: 28169879 Clinical Trial.
11,104 results
You have reached the last available page of results. Please see the User Guide for more information.